StockData
Agenus Inc logo

Agenus Inc (AGEN) stock

AGENNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 3/30
$6.21−0.08 (-1.27%)

Close on Nov 17, 2026Market cap $279.58MP/E –Yield –

Agenus market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Agenus's market cap was $299.16M on Nov 10, 2026, against $149.63M a year earlier. Over the last 5 years it ranged from $7.90M to $6.86B, with a median of $103.04M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 10, 2026$299.16M+190.3%
2025Dec 31, 2025$103.04M+73.4%
2024Dec 31, 2024$59.42M+337.7%
2023Jan 31, 2023$13.58M+8.8%
2022Dec 30, 2022$12.48M-10.1%
2021Dec 31, 2021$13.89M-99.8%
2018Jan 31, 2018$6.86B+10.7%
2017Dec 29, 2017$6.19B-13.1%
2016Dec 30, 2016$7.13B+8.1%
2015Dec 31, 2015$6.59B–

More Agenus figures

See a number that looks wrong?